Results 151 to 160 of about 6,360 (195)

Sevelamer-Associated Rectosigmoid Ulcers in an End-Stage Renal Disease Patient

, 2018
Pearl Princess Uy, Daniela Guerrero Vinsard, Safina Hafeez   +2 more
openalex   +1 more source

Dose relativity of sevelamer hydrochloride and lanthanum carbonate under real-world conditions: Implications for management of patients with end-stage renal disease and hyperphosphatemia [PDF]

, 2013
J. Brian Copley, Rosamund Wilson, Michael W. Keith   +2 more
openalex   +1 more source

Effectiveness of phosphate binders on mortality and cardiovascular disease in end-stage renal disease patients with hyperphosphatemia: a multicenter real-world cohort study. [PDF]

BMC Nephrol
Chaiyakittisopon K, Pattanaprateep O, Ponthongmak W, Kunakorntham P, Chuasuwan A, Ingsathit A, Mckay GJ, Attia J, Thakkinstian A.   +8 more
europepmc   +1 more source

An overview on adynamic bone disease clinical and therapeutical approaches [PDF]

, 2015
Mariana Barata Santos Barreira de Jesus
core  

Sevelamer as a phosphate binder in adult hemodialysis patients: an evidence-based review of its therapeutic value

, 2005
C Nadin
openalex   +2 more sources

Upadacitinib as a potential management option for diffuse cutaneous systemic sclerosis: A case report. [PDF]

SAGE Open Med Case Rep
Sarfaraz S, Chang J, Kirchhof MG.
europepmc   +1 more source

Use of ultrasound to assess the response to therapy for secondary hyperparathyroidism. [PDF]

, 2011
E, Colombini, G, Barsotti., MEOLA, Mario, PETRUCCI, Ilaria   +3 more
core   +1 more source

Cost-minimisation analysis of sucroferric oxyhydroxide and sevelamer carbonate in patients on dialysis with secondary hyperparathyroidism in the United Kingdom

, 2016
Joris van Stiphout, Peter Braunhofer, Viatcheslav Rakov, Matthias Schwenkglenks, Thomas D. Szucs, Patricia R. Blank   +5 more
openalex   +1 more source

Phosphate binder in dialysis: a cross-sectional study of patients' adherence and pill burden. [PDF]

J Bras Nefrol
Ferezin BBSC, Araújo LKRP, Lima CM, Abensur H, Pereira BJ, Dalboni MA, Moyses RMA, Elias RM.   +7 more
europepmc   +1 more source

Phosphate Binder Impairs Levothyroxine Absorption in a Hypothyroid Patient With End-Stage Renal Disease. [PDF]

Cureus
Ko M, Barai R, Brent G.
europepmc   +1 more source